Recon: EU states can offer early access to Pfizer’s COVID pill; Biogen to submit final designs for Aduhelm postmarketing study in March
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy